Fish & Richardson

IP firm Fish & Richardson continues to maintain a strong reputation in major West Coast markets, including San Diego and the Bay Area. The firm is highly recommended in the state for patent litigation and prosecution, areas the firm received significant awards attention by Managing IP. Additionally, the firm has a significant offering in the trademark area with experts focused on prosecution and enforcement.

Some of the firm’s leading patent practitioners in California include Juanita Brooks, Chris Marchese, John Phillips and Jonathan Singer. The West Coast patent group is active in prosecution, strategy, post-grant proceedings, jury trials and Hatch-Waxman disputes. Juanita Brooks is often hailed as one of the top patent litigators practicing nationally and is featured as one of the Top 250 Women in IP.

In the trademark area, Silicon Valley-based Lisa Greenwald-Swire is one of the firm’s go-to practitioners. She manages trademark portfolios, prosecution, enforcement and oppositions for clients.

In 2021, the firm won the US ITC Firm of the Year and US Specialty IP Firm of the Year awards from Managing IP.

For this year’s Managing IP Awards, Fish & Richardson was shortlisted for Patent Contentious Firm of the Year in the West, US Patent Prosecution Firm of the Year, US Patent Contentious Firm of the Year, and PTAB Firm of the Year. Juanita Brooks was shortlisted in the Outstanding IP Litigator category in California.

The firm’s distinctions were in part supported by notable litigation outcomes over the past year, including a denial of certiorarifrom the Supreme Court favoring client Gilead, and a Federal Circuit affirmance for Microsoft that found the client did not infringe patents covering computer systems.

Recently, the Fish team filed suit for Magnolia Medical in the District of Delaware against competitor Kurin alleging willful infringement of four patents related to blood collection devices.

Additional patent clients include Exela Pharma Sciences, Tide, SRI, Power Integrations, Momentive UV Coatings, iCeutica, Lipocine and CytomX Therapeutics.